Overview of NDC 60429-0176
NDC 60429-0176 corresponds to Selegiline Hydrochloride, a medication manufactured by Golden State Medical Supply, Inc. This drug is used primarily in the treatment of Parkinson's disease and, in some cases, major depressive disorder.
Market Context
Biopharma and Biotech Industry Trends
The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].
Pricing and Access Challenges
One of the significant issues facing the life sciences industry in 2025 is pricing and access to drugs. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies, highlighting the need for balanced pricing that ensures accessibility while maintaining profitability[5].
Regulatory Framework
National Drug Code (NDC) Directory
The NDC Directory, managed by the FDA, includes prescription drugs, OTC drugs, and insulin products. Each product is identified by a unique three-segment NDC number. For Selegiline Hydrochloride (NDC 60429-0176), the listing in the NDC Directory ensures compliance with FDA regulations and provides essential information such as drug strength, package size, and FDA-approved application numbers[4].
Market Dynamics
Competition from Generics and Biosimilars
The biopharma industry is facing increased competition from generic drugs and biosimilars. This competition is expected to intensify as patents expire, with over $300 billion in sales at risk through 2030 due to expiring patents on high-revenue products. This trend could impact the pricing strategy for Selegiline Hydrochloride, as generic versions may enter the market and reduce the pricing power of branded products[5].
Mergers and Acquisitions
Given the looming patent expirations, there is a heightened expectation of increased mergers and acquisitions (M&A) activity in the biopharma sector. This could lead to consolidation and potentially affect the market dynamics and pricing of drugs like Selegiline Hydrochloride[5].
Price Projections
Current Pricing
As of the latest available data, specific pricing information for NDC 60429-0176 is not provided in the sources. However, pricing for pharmaceuticals is generally influenced by factors such as production costs, market demand, regulatory approvals, and competition.
Future Pricing Trends
Given the industry trends:
- Competition from Generics: If generic versions of Selegiline Hydrochloride enter the market, prices are likely to decrease due to increased competition.
- Regulatory Environment: Any changes in regulatory frameworks that affect the cost of production or distribution could impact pricing.
- Market Demand: Changes in demand due to advancements in treatment options or shifts in patient needs could also influence pricing.
- M&A Activity: Consolidation in the industry might lead to pricing adjustments as companies seek to optimize their product portfolios.
Potential Price Scenarios
- Stable Pricing: If the market remains relatively stable with minimal competition from generics and no significant regulatory changes, the price of Selegiline Hydrochloride might remain steady.
- Price Decrease: With the entry of generic versions or increased competition, prices could decrease to remain competitive.
- Price Increase: If there are significant advancements in the drug's formulation or delivery method, or if there is a shortage of supply, prices might increase.
Key Takeaways
- The biopharma and biotech industries are experiencing rapid growth driven by technological advancements and evolving regulatory frameworks.
- Pricing and access to drugs are significant concerns for the industry in 2025.
- Competition from generics and biosimilars, along with patent expirations, will impact the pricing strategy for drugs like Selegiline Hydrochloride.
- M&A activity is expected to increase, which could affect market dynamics and pricing.
FAQs
What is the primary use of Selegiline Hydrochloride?
Selegiline Hydrochloride is primarily used in the treatment of Parkinson's disease and, in some cases, major depressive disorder.
How does the NDC Directory impact drug pricing?
The NDC Directory ensures compliance with FDA regulations and provides transparency in drug product information, which can influence pricing by ensuring that all products meet the same standards.
What are the key factors influencing the price of Selegiline Hydrochloride in 2025?
Key factors include competition from generics and biosimilars, regulatory changes, market demand, and M&A activity in the biopharma sector.
How might M&A activity affect the price of Selegiline Hydrochloride?
M&A activity could lead to consolidation, potentially affecting the market dynamics and pricing of drugs like Selegiline Hydrochloride as companies optimize their product portfolios.
What is the projected growth rate of the biopharma market between 2024 and 2029?
The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029[3].
Sources
- Find-A-Code: Golden State Medical Supply - NDC products.
- Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
- FDA: National Drug Code Database Background Information.
- Deloitte Insights: 2025 life sciences outlook.
